The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Eric Stonestreet, who played Cam on the ABC sitcom, said that he has slimmed down substantially while taking the GLP-1 ...

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Taking a glucagon-like peptide 1 (GLP-1) medication can be life-changing, but it comes with a learning curve. Along with ...

On Friday, the company’s health services unit Evernorth unveiled new programs in a reliable growth area: helping payers ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.